CRSP

CRISPR Therapeutics AGNASDAQHealthcare

$49.51+1.43%ClosedMarket Cap: $4.75B

As of 2026-04-06

Recent Analyst Ratings

Date	Firm	Action	Rating	Previous
2026-03-17	Piper Sandler	—	Overweight	—
2026-02-17	Chardan Capital	—	Buy	—
2026-02-13	Evercore ISI Group	—	Outperform	—
2026-02-13	TD Cowen	—	Hold	—
2026-02-13	Needham	—	Buy	—
2026-01-30	Citizens	—	Market Outperform	—
2025-12-23	Citizens	—	Market Outperform	—
2025-12-23	Needham	—	Buy	—
2025-11-26	Chardan Capital	—	Buy	—
2025-11-12	Citigroup	—	Buy	—

Forward Estimates

Period	EPS Est.	Revenue Est.	# Analysts
Fri Dec 31	$-3.85	$142.4M	16
Sun Dec 31	$-2.47	$533.7M	9
Mon Dec 31	$3.16	$1.91B	3
Tue Dec 31	$18.33	$4.86B	3